OCT4 and SOX2 have both been shown to upregulate PD-L1 expression in cervical cancer (79) and hepatocellular carcinoma (149), respectively, highlighting the necessity of PD-L1 expression for tumor reprogramming functions. The gene discussed is CD274; the disease is cervical carcinoma.